XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (24,558,648) $ (7,837,188) $ (19,265,644)
Adjustments to reconcile net loss to net cash used by operating activities:      
Non-cash compensation 2,183,317 1,193,949 1,173,743
Depreciation and amortization 731,578 660,788 581,532
Amortization of right of use asset 398,035    
Bad debt expense (recovery) (512) (102,310) 72,429
Foreign currency transaction (gains) losses 2,577,913 (2,607,139) 350,365
Stock-based compensation 4,020,819 3,513,671 1,666,024
Amortization of loan acquisition costs   322,812 115,206
Changes in operating assets and liabilities:      
Grants and accounts receivable 420,578 (326,860) (642,171)
Inventories (2,350,547) (461,512) (1,284,848)
Prepaid expenses and other current assets 280,915 (1,076,849) (953,888)
Other assets (135,857) 0 4,030
Accounts payable and accrued expenses 2,426,810 1,107,352 1,424,440
Net cash used by operating activities (14,005,599) (5,613,286) (16,758,782)
Cash flows from investing activities:      
Purchases of property and equipment (3,641,248) (708,395) (698,165)
Patent costs (640,013) (967,823) (821,952)
Net cash used by investing activities (4,281,261) (1,676,218) (1,520,117)
Cash flows from financing activities:      
Proceeds from long-term debt   1,410,900 5,000,000
Repayment of long-term debt   (16,410,900) 0
Final fee on long-term debt   (375,000) 0
Payment of loan acquisition costs   0 (4,212)
Equity contributions - net of fees incurred (90,000) 80,214,008 673,653
Proceeds from exercise of stock options 805,199 1,509,322 739,747
Proceeds from exercise of warrants   0 1,768,491
Net cash provided by financing activities 715,199 66,348,330 8,177,679
Effect of exchange rates on cash (24,774) 130,357 (35,199)
Net change in cash and cash equivalents (17,596,435) 59,189,183 (10,136,419)
Cash and cash equivalents at beginning of year 71,421,601 12,232,418 22,368,837
Cash and cash equivalents at end of year 53,825,166 71,421,601 12,232,418
Supplemental disclosure of cash flow information:      
Cash paid during the year for interest   1,127,647 1,059,541
Supplemental disclosure of non-cash financing activities:      
Settlement of accrued bonuses with restricted stock units $ 928,417 $ 657,780 $ 425,639